CAS: 2143467-62-1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | BPK-29 REF: 3D-TKD46762CAS: 2143467-62-1 | Min. 95% | A consultar | Mar 14 Ene 25 |
 | BPK-29 REF: TM-T13586CAS: 2143467-62-1 | 98% | 904,00 €~2.329,00 € | Mar 21 Ene 25 |
BPK-29
CAS:2143467-62-1
BPK-29 is a covalent chemical compound that was developed by the Bioprobes Laboratory, LLC. It …
Fórmula:
C26H32ClN3O3
Pureza:
Min. 95%
Peso molecular:
470 g/mol
Ref: 3D-TKD46762
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
BPK-29
CAS:2143467-62-1
BPK-29 disrupts NR0B1 binding and modifies C274, inhibiting growth in KEAP1-mutant cancers.
Fórmula:
C26H32ClN3O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
470
Ref: TM-T13586
| 25mg | 1.410,00 € | ||
| 50mg | 1.845,00 € | ||
| 100mg | 2.329,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
